Status:
COMPLETED
Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-85 years
Phase:
PHASE1
Brief Summary
This study is designed to investigate the safety, tolerability, and pharmacokinetics of PF-04447943 after single and multiple-dose administration to healthy young adult and elderly Japanese subjects, ...
Eligibility Criteria
Inclusion
- For young cohort, healthy male and/or female Japanese of non-child bearing potential between the age of 18 and 55 years, inclusive.
- For elderly cohort, healthy male and/or female Japanese of non-child bearing potential between the age of 65 and 85 years, inclusive.
- Body Mass Index (BMI) between 17.5 to 30.5 kg/m2, and a total body weight \>50 kg (110 lbs).
Exclusion
- Pregnant or nursing women; women of childbearing potential.
- Males who are unwilling to abstain from sexual intercourse or use a condom with all child-bearing potential women for the duration of the study.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00959803
Start Date
August 1 2009
End Date
November 1 2009
Last Update
December 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Glendale, California, United States, 91206